Dianthus Therapeutics (DNTH) Current Leases (2022 - 2025)
Dianthus Therapeutics' (DNTH) quarterly Current Leases came in at $367000.0 in Q4 2025, up 14.69% year-on-year from $320000.0 in Q4 2024, and up 69.12% quarter-over-quarter from $217000.0 in Q3 2025.
Dianthus Therapeutics (DNTH) Current Leases (2022 - 2025) Analysis & Trends
Dianthus Therapeutics' Current Leases history runs 4 years deep, the most recent figure standing at $367000.0 for Q4 2025.
- On a quarterly basis, Current Leases rose 14.69% year-over-year to $367000.0 in Q4 2025; TTM through Dec 2025 was $367000.0, a 14.69% increase from a year earlier, with the FY2025 full-year figure at $367000.0, up 14.69% from the prior year.
- Current Leases advanced to $367000.0 in Q4 2025 per DNTH's latest filing, from $217000.0 in the prior quarter.
- Across five years, Current Leases topped out at $3.6 million in Q3 2022 and bottomed at $211000.0 in Q2 2025.
- The 4-year median for Current Leases is $372000.0 (2024), against an average of $992785.7.
- Biggest YoY gain for Current Leases was 19.14% in 2023; the steepest drop was 88.59% in 2023.
- Year by year, Current Leases stood at $350000.0 in 2022, then gained by 19.14% to $417000.0 in 2023, then slipped by 23.26% to $320000.0 in 2024, then increased by 14.69% to $367000.0 in 2025.
- Per Business Quant, the three latest DNTH Current Leases figures stand at $367000.0 (Q4 2025), $217000.0 (Q3 2025), and $211000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Dianthus Therapeutics | 3.37 Bn | 2.97 Bn | - | 367,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 367,000.00 |
| Sep 30, 2025 | 217,000.00 |
| Jun 30, 2025 | 211,000.00 |
| Mar 31, 2025 | 226,000.00 |
| Dec 31, 2024 | 320,000.00 |
| Sep 30, 2024 | 311,000.00 |
| Jun 30, 2024 | 377,000.00 |
| Mar 31, 2024 | 400,000.00 |
| Dec 31, 2023 | 417,000.00 |
| Sep 30, 2023 | 413,000.00 |
| Dec 31, 2022 | 350,000.00 |
| Sep 30, 2022 | 3.62 Mn |
| Jun 30, 2022 | 3.42 Mn |
| Mar 31, 2022 | 3.25 Mn |